SCHEMBL4906211

SCHEMBL4906211

CCN(Sc1ccc(Oc2cc(Cl)cc(Cl)c2)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)OC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.41
ALDH1A1 P00352 2/20 0.41
EPAS1 Q99814 1/20 0.38
CARM1 Q86X55 1/20 0.33
PRMT6 Q96LA8 1/20 0.33
MCL1 Q07820 7/20 0.33
BCL2L1 Q07817 5/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
NPC1 O15118 1/20 0.32
LMNA P02545 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
KDM4E B2RXH2 2/20 0.32
HSD17B10 Q99714 1/20 0.32
P2RX3 P56373 1/20 0.32
CYP2C9 P11712 1/20 0.31
FFAR4 Q5NUL3 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4902692 0.91 MCL1 (0.39) TSHRALDH1A1EPAS1MCL1BCL2L1
SCHEMBL4902983 0.90 ALDH1A1 (0.39) TSHRALDH1A1MCL1SMN1; SMN2CYP1A2
SCHEMBL4904210 0.90 KDM4E (0.40) TSHRALDH1A1SMN1; SMN2CYP1A2CYP2C19
SCHEMBL4895549 0.89 ALDH1A1 (0.39) TSHRALDH1A1SMN1; SMN2CYP1A2CYP2C19
SCHEMBL4905774 0.89 TSHR (0.41) TSHRALDH1A1EPAS1SMN1; SMN2CYP1A2
SCHEMBL4905600 0.89 ALDH1A1 (0.38) TSHRALDH1A1EPAS1SMN1; SMN2CYP1A2
SCHEMBL4902601 0.89 ALDH1A1 (0.38) TSHRALDH1A1SMN1; SMN2CYP1A2CYP2C19
SCHEMBL5930735 0.88 TSHR (0.36) TSHRALDH1A1EPAS1SMN1; SMN2NPC1
SCHEMBL4899783 0.87 ALDH1A1 (0.40) TSHRALDH1A1SMN1; SMN2LMNAKDM4E
SCHEMBL4899562 0.86 ALDH1A1 (0.36) TSHRALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD TSHR 412/4885ALDH1A1 2664/4885EPAS1 103/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD TSHR 400/4885ALDH1A1 2956/4885EPAS1 100/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD TSHR 400/4885ALDH1A1 2956/4885EPAS1 100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.